Have you ever checked your credit report and wondered about the term “tradelines”? Or maybe you’ve heard someone talk about ...

People process visual content up to 60,000 times faster than big blocks of text. When used strategically, images, graphics, ...

In the 25-year history of modern Nigerian mainstream music, we have seen unforgettable hip-hop records that defined eras and ...

A leading global democracy research institute says democratic “backsliding” must be turned around quickly—warning that after ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.

Join Adam Arellano, Field CTO at Traceable, and Shawn Brady, Head of Global Partnerships at AWS, for an exclusive webinar ...

Nitisinone, a medication typically prescribed for individuals with rare inherited diseases, has been shown to make human ...

Low doses of a drug already approved for treating rare genetic conditions in humans kills mosquitoes dead. Scientists say it ...

Part of the excitement around MIND of Pepe stems from its blend of advanced AI functionality and meme culture, effectively moving the sector beyond tokens that merely represent internet jokes.

Regenxbio is ranked Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and buyout potential.

Most firms test security annually—configuration drift and missed gaps demand continuous testing to stay resilient.

Nitisinone was shown to last longer than ivermectin in the human bloodstream, and was able to kill not only mosquitoes of all ages -- including the older ones that are most likely to transmit malaria ...